BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26733561)

  • 21. [Characteristics of gene structure in facioscapulohumeral muscular dystrophy-related 4q35 subtelomere and genotype-phenotype correlation in Chinese Han population].
    Wang ZQ; Wu ZY; Wang N; Lin MT; Murong SX
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):304-9. PubMed ID: 19563705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy.
    van Overveld PG; Enthoven L; Ricci E; Rossi M; Felicetti L; Jeanpierre M; Winokur ST; Frants RR; Padberg GW; van der Maarel SM
    Ann Neurol; 2005 Oct; 58(4):569-76. PubMed ID: 16178028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 1 FSHD with 6-10 Repeated Units: Factors Underlying Severity in Index Cases and Disease Penetrance in Their Relatives Attention.
    Salort-Campana E; Fatehi F; Beloribi-Djefaflia S; Roche S; Nguyen K; Bernard R; Cintas P; Solé G; Bouhour F; Ollagnon E; Sacconi S; Echaniz-Laguna A; Kuntzer T; Levy N; Magdinier F; Attarian S
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2.
    Lemmers RJ; Goeman JJ; van der Vliet PJ; van Nieuwenhuizen MP; Balog J; Vos-Versteeg M; Camano P; Ramos Arroyo MA; Jerico I; Rogers MT; Miller DG; Upadhyaya M; Verschuuren JJ; Lopez de Munain Arregui A; van Engelen BG; Padberg GW; Sacconi S; Tawil R; Tapscott SJ; Bakker B; van der Maarel SM
    Hum Mol Genet; 2015 Feb; 24(3):659-69. PubMed ID: 25256356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical activity practiced at a young age is associated with a less severe subsequent clinical presentation in facioscapulohumeral muscular dystrophy.
    Bettio C; Banchelli F; Salsi V; Vicini R; Crisafulli O; Ruggiero L; Ricci G; Bucci E; Angelini C; Berardinelli A; Bonanno S; D'Angelo MG; Di Muzio A; Filosto M; Frezza E; Maggi L; Mongini T; Pegoraro E; Rodolico C; Scarlato M; Vattemi G; Velardo D; Tomelleri G; D'Amico R; D'Antona G; Tupler R
    BMC Musculoskelet Disord; 2024 Jan; 25(1):35. PubMed ID: 38183077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of variants in the 4q35 gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype.
    Puppo F; Dionnet E; Gaillard MC; Gaildrat P; Castro C; Vovan C; Bertaux K; Bernard R; Attarian S; Goto K; Nishino I; Hayashi Y; Magdinier F; Krahn M; Helmbacher F; Bartoli M; Lévy N
    Hum Mutat; 2015 Apr; 36(4):443-53. PubMed ID: 25615407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Facioscapulohumeral muscular dystrophy type 2].
    Sacconi S; Desnuelle C
    Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and genetic characteristics of facioscapulohumeral muscular dystrophy Landuzi-Dezherina type 1].
    Dadali EL; Sharkova IV; Zernov NV; Rudenskaya GE; Skoblov MY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):122-128. PubMed ID: 29265097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1.
    Larsen M; Rost S; El Hajj N; Ferbert A; Deschauer M; Walter MC; Schoser B; Tacik P; Kress W; Müller CR
    Eur J Hum Genet; 2015 Jun; 23(6):808-16. PubMed ID: 25370034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 5-year clinical follow-up study from the Italian National Registry for FSHD.
    Vercelli L; Mele F; Ruggiero L; Sera F; Tripodi S; Ricci G; Vallarola A; Villa L; Govi M; Maranda L; Di Muzio A; Scarlato M; Bucci E; Maggi L; Rodolico C; Moggio M; Filosto M; Antonini G; Previtali S; Angelini C; Berardinelli A; Pegoraro E; Siciliano G; Tomelleri G; Santoro L; Mongini T; Tupler R
    J Neurol; 2021 Jan; 268(1):356-366. PubMed ID: 32813049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and genetic features of somatic mosaicism in facioscapulohumeral dystrophy.
    Qiu L; Ye Z; Lin L; Wang L; Lin X; He J; Lin F; Xu G; Cai N; Jin M; Chen H; Lin M; Wang N; Wang Z
    J Med Genet; 2020 Nov; 57(11):777-785. PubMed ID: 32170003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection.
    Lemmers RJ; Osborn M; Haaf T; Rogers M; Frants RR; Padberg GW; Cooper DN; van der Maarel SM; Upadhyaya M
    Neurology; 2003 Jul; 61(2):178-83. PubMed ID: 12874395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
    Bodega B; Ramirez GD; Grasser F; Cheli S; Brunelli S; Mora M; Meneveri R; Marozzi A; Mueller S; Battaglioli E; Ginelli E
    BMC Biol; 2009 Jul; 7():41. PubMed ID: 19607661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
    Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FSHD1 and FSHD2 form a disease continuum.
    Sacconi S; Briand-Suleau A; Gros M; Baudoin C; Lemmers RJLF; Rondeau S; Lagha N; Nigumann P; Cambieri C; Puma A; Chapon F; Stojkovic T; Vial C; Bouhour F; Cao M; Pegoraro E; Petiot P; Behin A; Marc B; Eymard B; Echaniz-Laguna A; Laforet P; Salviati L; Jeanpierre M; Cristofari G; van der Maarel SM
    Neurology; 2019 May; 92(19):e2273-e2285. PubMed ID: 30979860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD).
    Zeng W; de Greef JC; Chen YY; Chien R; Kong X; Gregson HC; Winokur ST; Pyle A; Robertson KD; Schmiesing JA; Kimonis VE; Balog J; Frants RR; Ball AR; Lock LF; Donovan PJ; van der Maarel SM; Yokomori K
    PLoS Genet; 2009 Jul; 5(7):e1000559. PubMed ID: 19593370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
    Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
    BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low D4Z4 copy number and gender difference in Korean patients with facioscapulohumeral muscular dystrophy type 1.
    Park HJ; Hong JM; Lee JH; Lee HS; Shin HY; Kim SM; Ki CS; Lee JH; Choi YC
    Neuromuscul Disord; 2015 Nov; 25(11):859-64. PubMed ID: 26319123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review.
    Chen TH; Wu YZ; Tseng YH
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct interplay between two candidate genes in FSHD muscular dystrophy.
    Ferri G; Huichalaf CH; Caccia R; Gabellini D
    Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.